Haleon plc (HLN) Price-to-Earnings (P/E) Ratio
Price: $10.28
Market Cap: $46.37B
Avg Volume: 11.55M
Market Cap: $46.37B
Avg Volume: 11.55M
Country: GB
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Haleon plc's P/E ratios across different time periods:
- TTM: 23.89
- Annual: 23.89
- Quarterly: 37.28
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.13
- Price-to-Sales (P/S) Ratio: 3.07
Annual Ratios
Haleon plc Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
23.89
P/B Ratio (Annual)
2.13
P/S Ratio (Annual)
3.07
Haleon plc Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 23.89 | 2.13 | 3.07 |
| 2023 | 28.69 | 1.81 | 2.66 |
| 2022 | 28.52 | 1.85 | 2.78 |
| 2021 | 20.49 | 1.08 | 2.98 |
| 2020 | 24.87 | 1.09 | 2.88 |
| 2019 | 43.47 | 1.04 | 3.36 |
Related Metrics
Explore detailed financial metrics and analysis for HLN.